INVA
Biotechnology · Healthcare
Board Member, CEO
Board Member
Innoviva, Inc. (INVA)Equibles does not estimate personal net worth.
Get an email with a short summary when Innoviva, Inc. publishes a filing, an earnings call transcript or a press release.
Get INVA alertsPavel Raifeld is recorded as Board Member and CEO at Innoviva, Inc. (INVA). The newest filing on record that lists Pavel Raifeld as Board Member and CEO at Innoviva, Inc. (INVA) is dated March 24, 2026. The proxy statement of Innoviva, Inc. reports total compensation of $5,400,197 for Pavel Raifeld in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 6 fiscal years. Pavel Raifeld has spoken on 1 investor event across 1 company, most recently for Innoviva, Inc. on June 8, 2026. Innoviva, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Innoviva, Inc. includes Larry Edwards (CEO), Stephen Basso (CFO), Marianne Zhen (Chief Accounting Officer) and 7 others.
“It's a pleasure to be here, and I appreciate an opportunity to attend the conference.”
Start not stated–present
Last confirmed March 24, 2026
Start not stated–present
Last confirmed March 24, 2026
INVA
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Innoviva, Inc. (INVA) | Chief Executive Officer | $600,000 | $5,400,197 |
| 2024 | Innoviva, Inc. (INVA) | Chief Executive Officer | $503,333 | $2,716,420 |
| 2023 | Innoviva, Inc. (INVA) | Chief Executive Officer | $485,000 | $868,648 |
| 2022 | Innoviva, Inc. (INVA) | Chief Executive Officer | $440,000 | $1,798,966 |
| 2021 | Innoviva, Inc. (INVA) | Chief Executive Officer | $391,458 | $1,271,138 |
| 2020 | Innoviva, Inc. (INVA) | Chief Executive Officer | $222,000 | $1,943,968 |